“Rather, I see RWE starting to take its rightful place as a complement to RCT. For example, 50% of the new cancer drugs approved using surrogate endpoints showed no benefit in overall survival.

Increasing interest in real-world evidence (RWE) across all stakeholder groups has the industry buzzing about its current role in clinical trials and the potential impact of expanded use.

ORLANDO, Fla. — Putting names and faces to a drug crisis was the mission Thursday as the Drug Enforcement Administration’s Miami field division held the first family summit event in Orlando to ...

Easterly Government Properties, Inc. (NYSE: DEA) is based in Washington, D.C., and focuses primarily on the acquisition, development and management of Class A commercial properties that are leased ...

The DEA may be close to reaching a decision on rescheduling marijuana to recognize the medical benefits. The DEA spokesman Russ Baer said no determination has been made yet on rescheduling pot, but ...

A retired DEA agent who shot another man during a road-rage encounter in Florida is now facing a charge of second-degree murder with a firearm. Bradley Sosnowsky, who was a DEA special agent from 1999 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Company History - Honeywell Automation India Ltd. YEAR EVENTS 1984 - The Company was incorporated on 13th January, as a private limited company under the name of Tata Process Control Pvt. Ltd. 1987 - ...